Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.

Berry Genomics plans to expand its sequencing capability to clinical assays like congenital adrenal hyperplasia and spinal muscular atrophy.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended September 30, 2025.

Catecholamines, such as dopamine and adrenaline, are hormones produced by the brain, nerve tissues, and adrenal glands. They are responsible for the body’s “fight-or-flight” response. Dopamine, ...

As of Friday, November 07, Crinetics Pharmaceuticals, Inc.’s CRNX share price has dipped by 8.90%, which has investors ...